CN Patent

CN112955453B — 作为选择性Trk抑制剂的吡唑并嘧啶衍生物

Assigned to Yantai Chuanghe Biotechnology Co ltd · Expires 2022-04-19 · 4y expired

What this patent protects

本发明公开了式(Ⅱ)所示化合物、其互变异构体或其药学上可接受的盐，并涉及其在制备治疗实体瘤相关疾病的药物的应用。

USPTO Abstract

本发明公开了式(Ⅱ)所示化合物、其互变异构体或其药学上可接受的盐，并涉及其在制备治疗实体瘤相关疾病的药物的应用。

Drugs covered by this patent

larotrectinib-sulfate (LAROTRECTINIB SULFATE)

Patent Metadata

Patent number: CN112955453B
Jurisdiction: CN
Classification: —
Expires: 2022-04-19
Drug substance claim: No
Drug product claim: No
Assignee: Yantai Chuanghe Biotechnology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.